Guidance for BioCryst Pharmaceuticals, Inc. (BCRX)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2025 | N/A | N/A | $590.00M – 600.00M | $626.10M | = Maintained | Details |
| 2025 | N/A | N/A | $580.00M – 600.00M | $608.40M | = Maintained | Details |
| 2025 | N/A | N/A | $580.00M – 600.00M | $563.60M | = Maintained | Details |
| 2024 | N/A | N/A | $443.00M – 448.00M | $436.30M | = Maintained | Details |
| 2024 | N/A | N/A | $390.00M – 400.00M | $395.10M | = Maintained | Details |
| Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2012 | N/A | N/A | $5.00M | N/A | = Maintained | Details |
